Professional Documents
Culture Documents
on Antimicrobial Resistance
in Indonesia
• The recommendations of the 68th World Health Assembly in 2015, Member States are
urged to develop strategies and plans on the implementation of AMR control
• A one health priority research agenda for antimicrobial resistance (World Health
Organization, Food and Agriculture Organization of the United Nations, United Nations
Environment Programme and World Organisation for Animal Health, 2023)
Introduction
• Antimicrobial resistance (AMR) is an increasing threat to public health and sustainable
development.
• The increasing emergence and spread of AMR compromises our ability to treat infections and
to manage AMR-associated economic impacts across all sectors.
• Infectious diseases caused by multiple drug resistant organisms (MDRO) have become more
worrying at the national and global levels. Several MDRO causing infections in hospitals are
Enterobacteiacear, Pseudomonas spp., Acinetobacter spp., Staphylococcus spp.,
• Indonesia uses more antibiotics, partly due to increasing income, low-cost antibiotics, lack of
control over the use of antimicrobials in hospitals, and sales of over-the- counter drugs.
Antimicrobial Resistance Issues
• Antimicrobials are still used inappropriately, excessively, and imprudently in humans, animals,
and plants.
• Antimicrobial resistance has the potential to impede various national development programs in the
sector of disease control and food security.
• Infectious disease treatment failure due to antimicrobial resistance has become an issue for public
health and animal health, resulting in an increased burden on public health and animal health
funding.
• Antimicrobial resistance control is still performed on a sectoral basis, thus it is not handled
optimally.
• Antibiotics are being sold without a doctor’s or veterinarian’s prescription.
Highest-priority research areas